{
  "context": {
    "rules": [
      "Rule1: If the game changer drug completed phase II, then it passes the efficacy test.",
      "Rule2: Provided that the controlled substance requires authorization, the drug is authorized for market.",
      "Rule3: Either the controlled substance is over the counter or it requires authorization.",
      "Rule4: If the manufacturer is under investigation, then it is accused of misconduct.",
      "Rule5: Either the FDA receives a warning letter or, if the manufacturer is under investigation, the drug is authorized for market.",
      "Rule6: In the event that the manufacturer receives a fine, it is not the case that the FDA receives a warning letter.",
      "Rule7: The manufacturer receives a fine or the manufacturer receives a suspension.",
      "Rule8: Should the manufacturer receive a suspension, its license is revoked.",
      "Rule9: Provided that the manufacturer appeals the decision, it wins the appeal.",
      "Rule10: If the manufacturer appeals the decision, then it does not win the appeal.",
      "Rule11: If the manufacturer violates regulations, then it violates a patent.",
      "Rule12: Either the manufacturer violates regulations or, if the drug is not authorized for market, the clinical trial is not approved.",
      "Rule13: Should the manufacturer violate a patent, it infringes a copyright.",
      "Rule14: Either the manufacturer settles the case or, if it infringes a copyright, it faces a lawsuit.",
      "Rule15: Provided that the manufacturer fails the compliance check, it does not receive an audit.",
      "Rule16: The manufacturer fails the compliance check or it passes the compliance check.",
      "Rule17: If the manufacturer passes the compliance check, then it does not receive an audit.",
      "Rule18: If the advisory committee gives a positive review, then, if it is not the case that (either the game changer drug passes the safety test or it passes the efficacy test) implies conditional approval, the drug receives full approval.",
      "Rule19: Either the advisory committee gives a positive review or it gives a negative review.",
      "Rule20: The manufacturer is compliant with the FDA or it does not violate regulations.",
      "Rule21: In the event that the advisory committee gives a negative review, then, provided that (neither the game changer drug passes the safety test nor it passes the efficacy test) does not lead to conditional approval, the drug receives full approval.",
      "Rule22: Should the controlled substance require a prescription, it is not exempt from authorization.",
      "Rule23: Either the controlled substance is a restricted substance or it is not a banned substance.",
      "Rule24: The manufacturer challenges the ruling or it does not appeal the decision.",
      "Rule25: Given that the manufacturer accepts the penalty, it does not challenge the ruling.",
      "Rule26: The manufacturer accepts the penalty or it contests the penalty.",
      "Rule27: If the manufacturer contests the penalty, then it does not challenge the ruling.",
      "Rule28: In the event that the game changer drug has approval, the drug is authorized for market.",
      "Rule29: Either the game changer drug has approval or the blockbuster drug has approval.",
      "Rule30: Should the manufacturer request a hearing, it files a petition.",
      "Rule31: The manufacturer accepts the judgment or, if it submits an appeal, it requests a hearing.",
      "Rule32: If the manufacturer is investigated for fraud, then the drug is authorized for market.",
      "Rule33: Provided that the manufacturer is accused of misconduct, it is charged with fraud.",
      "Rule34: Whenever the manufacturer is charged with fraud, it is investigated for fraud.",
      "Rule35: Either the manufacturer commits a serious violation or, if (the manufacturer being under investigation does not imply the drug is authorized for market), it does not commit a minor infraction.",
      "Rule36: If the game changer drug passes the safety test, then the drug is authorized for market.",
      "Rule37: In the event that the game changer drug passes the efficacy test, the drug is authorized for market.",
      "Rule38: Provided that the game changer drug completed phase III, it passes the safety test.",
      "Rule39: Either the game changer drug completed phase III or it completed phase II.",
      "Rule40: If it is not the case that (the manufacturer being under investigation implies the drug is authorized for market), then the manufacturer commits a minor infraction.",
      "Rule41: Given that (the manufacturer's license being revoked does not imply the FDA does not receive a warning letter), the manufacturer appeals the decision.",
      "Rule42: Provided that (the manufacturer's license being revoked does not imply the FDA does not receive a warning letter), the manufacturer submits an appeal.",
      "Rule43: In the event that (the manufacturer's license being revoked does not imply the FDA does not receive a warning letter), the manufacturer does not file a petition.",
      "Rule44: Should (the blockbuster drug having approval not imply the drug is authorized for market), the manufacturer receives an audit.",
      "Rule45: If (the blockbuster drug having approval does not imply the drug is authorized for market), then the manufacturer commits a minor violation.",
      "Rule46: In the event that (the game changer drug does not pass the safety test and it does not pass the efficacy test), the drug does not receive conditional approval.",
      "Rule47: Should (neither the game changer drug passes the safety test nor it passes the efficacy test) not imply conditional approval, the drug does not receive full approval.",
      "Rule48: If the controlled substance does not require authorization, then it is exempt from authorization.",
      "Rule49: Provided that the controlled substance does not require a prescription, it is a banned substance.",
      "Rule50: In the event that the drug is not authorized for market, the clinical trial is approved."
    ],
    "facts": [
      "Fact1: The manufacturer is under investigation.",
      "Fact2: It is not the case that the controlled substance is over the counter.",
      "Fact3: The manufacturer does not face a lawsuit.",
      "Fact4: The manufacturer does not settle the case.",
      "Fact5: The manufacturer is not compliant with the FDA.",
      "Fact6: The controlled substance is not a restricted substance.",
      "Fact7: The manufacturer does not accept the judgment.",
      "Fact8: The manufacturer does not commit a serious violation.",
      "Fact9: The manufacturer does not commit a minor violation."
    ]
  },
  "question": "The drug is authorized for market."
}